Activity Overview
This online, on-demand virtual symposium brings together renowned experts in multiple myeloma (MM). In this educational program, these experts use real-world cases and focused data reviews to examine frontline quadruplet therapy, administration considerations for therapy, and optimal sequencing of CAR-T, bispecific, and ADC therapies for their patients, equipping clinicians with practical strategies to translate emerging evidence into individualized treatment plans for patients with MM.
This
educational activity is an archive of the live presentation held on May 15, 2026.
Target Audience
This
educational activity is directed toward hematologist-oncologists, advanced
practice providers, nurses, pharmacists, and other health care providers
involved in the diagnosis and treatment of MM.
Learning Objectives
Upon successful completion of this activity, you should be better prepared to:
- Evaluate recent efficacy and safety data from pivotal trials assessing new and emerging therapies for MM
- Apply disease-specific and individual patient considerations to optimize personalized treatment planning in MM
- Assess the evolving evidence on using MRD assessments to guide the choice and duration of maintenance therapy
- Implement the latest best practices for preventing and managing treatment-related toxicities in patients with MM
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here
